Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
- Author:
Minkyung HAN
1
;
Yoon Suk JUNG
;
Jae Hee CHEON
;
Sohee PARK
Author Information
- Publication Type:Original Article
- Keywords: Ulcerative colitis; infliximab; adalimumab
- MeSH: Adalimumab; Asian Continental Ancestry Group; Biological Products; Biological Therapy; Colectomy; Colitis, Ulcerative; Emergency Service, Hospital; Follow-Up Studies; Hospitalization; Humans; Immunologic Factors; Infliximab; National Health Programs; Ulcer
- From:Yonsei Medical Journal 2020;61(1):48-55
- CountryRepublic of Korea
- Language:English
- Abstract:
